DK149191C - Antiviralt virksom farmaceutisk olie-i-vand-formulering af 9-(2-hydroxyethoxymethyl)guanin(acyclovir) - Google Patents

Antiviralt virksom farmaceutisk olie-i-vand-formulering af 9-(2-hydroxyethoxymethyl)guanin(acyclovir)

Info

Publication number
DK149191C
DK149191C DK321681A DK321681A DK149191C DK 149191 C DK149191 C DK 149191C DK 321681 A DK321681 A DK 321681A DK 321681 A DK321681 A DK 321681A DK 149191 C DK149191 C DK 149191C
Authority
DK
Denmark
Prior art keywords
hydroxyethoxymethyl
acyclovir
guanine
active pharmaceutical
water formulation
Prior art date
Application number
DK321681A
Other languages
English (en)
Other versions
DK149191B (da
DK321681A (da
Inventor
Trevor Mervyn Jones
Alan Robert White
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26276273&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK149191(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of DK321681A publication Critical patent/DK321681A/da
Publication of DK149191B publication Critical patent/DK149191B/da
Application granted granted Critical
Publication of DK149191C publication Critical patent/DK149191C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK321681A 1980-07-18 1981-07-17 Antiviralt virksom farmaceutisk olie-i-vand-formulering af 9-(2-hydroxyethoxymethyl)guanin(acyclovir) DK149191C (da)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8023645 1980-07-18
GB8023645 1980-07-18
GB8033218 1980-10-15
GB8033218A GB2080106B (en) 1980-07-18 1980-10-15 Acyclovin preparations

Publications (3)

Publication Number Publication Date
DK321681A DK321681A (da) 1982-01-19
DK149191B DK149191B (da) 1986-03-10
DK149191C true DK149191C (da) 1986-09-08

Family

ID=26276273

Family Applications (1)

Application Number Title Priority Date Filing Date
DK321681A DK149191C (da) 1980-07-18 1981-07-17 Antiviralt virksom farmaceutisk olie-i-vand-formulering af 9-(2-hydroxyethoxymethyl)guanin(acyclovir)

Country Status (30)

Country Link
EP (1) EP0044543B1 (da)
AR (1) AR225680A1 (da)
AT (1) AT381025B (da)
AU (1) AU547391B2 (da)
BG (1) BG60450B2 (da)
CA (1) CA1172169A (da)
CS (1) CS229674B2 (da)
CY (1) CY1309A (da)
DD (1) DD203464A5 (da)
DE (1) DE3163982D1 (da)
DK (1) DK149191C (da)
ES (1) ES504046A0 (da)
FI (1) FI76255C (da)
GB (1) GB2080106B (da)
GR (1) GR75104B (da)
HK (1) HK95485A (da)
HU (1) HU185936B (da)
IE (1) IE51120B1 (da)
IL (1) IL63351A (da)
IT (1) IT1171399B (da)
MC (1) MC1408A1 (da)
MY (1) MY8600389A (da)
NO (1) NO155038C (da)
NZ (1) NZ197744A (da)
PH (1) PH16308A (da)
PL (1) PL135416B1 (da)
PT (1) PT73391B (da)
RO (1) RO82678A (da)
SG (1) SG72085G (da)
ZW (1) ZW17181A1 (da)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0095813A3 (en) * 1982-06-01 1985-05-08 THE PROCTER & GAMBLE COMPANY Penetrating topical pharmaceutical compositions containing 9-(2-hydroxyethoxymethyl) guanine
US4557934A (en) 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
GB8602346D0 (en) * 1986-01-30 1986-03-05 Wellcome Found Antiviral combinations
GB8917959D0 (en) * 1989-08-05 1989-09-20 Beecham Group Plc Pharmaceutical formulation
US6469015B1 (en) 1990-01-26 2002-10-22 Novartis International Pharmaceutical Ltd Pharmaceutical formulation
GB9001886D0 (en) * 1990-01-26 1990-03-28 Beecham Group Plc Pharmaceutical formulation
ATE158222T1 (de) * 1992-03-20 1997-10-15 Unichema Chemie Bv Formtrennzusammensetzung
DK169121B1 (da) * 1992-09-09 1994-08-22 Gea Farmaceutisk Fabrik As Antiviralt virksom farmaceutisk olie-i-vand-emulsion indeholdende 9-[(2-hydroxyethoxy)methyl]guanin (acyclovir) eller et salt eller en ester deraf
DE4416674C2 (de) * 1994-05-11 1997-01-30 Rentschler Arzneimittel Topische Zubereitung enthaltend Aciclovir
DE19517147C2 (de) * 1995-05-10 1999-07-01 Hexal Pharmaforschung Gmbh Aciclovir-Zubereitung
WO1997034607A1 (en) * 1996-03-20 1997-09-25 Glaxo Group Limited Topical formulations of aciclovir
GB9611167D0 (en) * 1996-05-29 1996-07-31 Glaxo Group Ltd Medicaments
GB9718568D0 (en) 1997-09-03 1997-11-05 Chauvin Pharmaceuticals Limite Compositions
GB9718791D0 (en) * 1997-09-05 1997-11-12 Glaxo Group Ltd Medicaments
ITMI981528A1 (it) * 1998-07-03 2000-01-03 Recordati Ind Chimica E Farma Formulazioni topiche di aciclovir
US7223387B2 (en) 1998-11-18 2007-05-29 Medivir Ab Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester
GB9828620D0 (en) * 1998-12-23 1999-02-17 Glaxo Group Ltd Medicaments
FR2837102B1 (fr) * 2002-03-18 2004-10-08 Palbian Snc Composition a l'etat de gel aqueux, procede de fabrication et utilisation pour la fabrication d'un medicament, notamment antiherpetique
US8697712B2 (en) * 2004-04-05 2014-04-15 Laboratorios Liomont, S.A. De C.V. Presentation of an antiviral pharmaceutical composition
EP2005824A1 (de) † 2007-06-21 2008-12-24 Bayer CropScience AG Wirkstoffsuspensionen in Glycerin
EP3337512A1 (en) 2015-08-17 2018-06-27 Sanovel Ilac Sanayi ve Ticaret A.S. A topical antiviral composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3892857A (en) * 1972-11-24 1975-07-01 Squibb & Sons Inc Steroid formulation
ZA738657B (en) * 1973-01-05 1974-10-30 Hoffmann La Roche Emulsions
GB1478009A (en) * 1973-04-02 1977-06-29 Glaxo Lab Ltd Pharmaceutical compositions
US4199574A (en) * 1974-09-02 1980-04-22 Burroughs Wellcome Co. Methods and compositions for treating viral infections and guanine acyclic nucleosides
GB1543907A (en) * 1975-02-19 1979-04-11 Dermal Labor Ltd Steroid compositions
US3934013A (en) * 1975-02-21 1976-01-20 Syntex (U.S.A.) Inc. Pharmaceutical composition
US4049802A (en) * 1975-03-19 1977-09-20 Research Corporation Zinc sulfadiazine and its use in the treatment of burns
GB1554720A (en) * 1975-07-10 1979-10-24 Nyegaard & Co As Pyridthione derivatives
US4141976A (en) * 1976-01-05 1979-02-27 The Regents Of The University Of Michigan Process for alleviating proliferative skin diseases
DE2847975A1 (de) * 1978-11-04 1980-05-14 Merck Patent Gmbh Verfahren zur bindung von freiem formaldehyd in pharmazeutischen und kosmetischen zubereitungen

Also Published As

Publication number Publication date
DK149191B (da) 1986-03-10
CS229674B2 (en) 1984-06-18
ES8305363A1 (es) 1983-04-01
FI76255C (fi) 1990-03-14
DE3163982D1 (en) 1984-07-12
GB2080106A (en) 1982-02-03
IT1171399B (it) 1987-06-10
ATA318081A (de) 1986-01-15
PH16308A (en) 1983-09-05
AU547391B2 (en) 1985-10-17
PL232259A1 (en) 1983-07-04
PL135416B1 (en) 1985-10-31
AT381025B (de) 1986-08-11
BG60450B2 (bg) 1995-04-28
IE811617L (en) 1982-01-18
IE51120B1 (en) 1986-10-01
CA1172169A (en) 1984-08-07
SG72085G (en) 1986-05-02
IL63351A (en) 1983-10-31
FI812257L (fi) 1982-01-19
EP0044543B1 (en) 1984-06-06
HU185936B (en) 1985-04-28
PT73391A (en) 1981-08-01
GB2080106B (en) 1984-03-07
NO155038C (no) 1987-02-04
AU7307381A (en) 1982-01-21
EP0044543A1 (en) 1982-01-27
CY1309A (en) 1985-12-06
NO155038B (no) 1986-10-27
FI76255B (fi) 1988-06-30
HK95485A (en) 1985-12-06
GR75104B (da) 1984-07-13
MY8600389A (en) 1986-12-31
IL63351A0 (en) 1981-10-30
IT8148925A0 (it) 1981-07-17
MC1408A1 (fr) 1982-07-16
DK321681A (da) 1982-01-19
ZW17181A1 (en) 1983-02-23
RO82678A (ro) 1984-05-23
PT73391B (en) 1983-06-15
ES504046A0 (es) 1983-04-01
NO812464L (no) 1982-01-19
NZ197744A (en) 1983-05-10
DD203464A5 (de) 1983-10-26
AR225680A1 (es) 1982-04-15

Similar Documents

Publication Publication Date Title
DK149191C (da) Antiviralt virksom farmaceutisk olie-i-vand-formulering af 9-(2-hydroxyethoxymethyl)guanin(acyclovir)
NO830316L (no) Fremgangsmaate for fremstilling av antivirale purinderivater
DK150304C (da) Analogifremgangsmaade til fremstilling af 9-(1,3-dihydroxy-2-propoxymethyl)guanin eller farmaceutisk acceptable salte deraf
DE3485225D1 (de) Antivirale guanin-derivate.
YU40080B (en) Pocess for obtaining 9-(2-hydroxyethoxymethyl)guanine derivatives of purine
HK82292A (en) Guanine compounds and their use for the preparation of antiviral agents
LV5264A3 (lv) Panemiens guanina atvasinajumu vai to farmaceitiski pielietojamu skabju-aditivo saju iegusanai
FI840890A0 (fi) Foerbaettringar i eller angaoende difluoro innehaollande antivirala aemnen
DE3671227D1 (de) 9-substituierte guaninmonohydrate.
AU1527983A (en) Topical pharmaceutical compositions containing 9- (2-hydroxyethoxymethyl) guanine
FI782527A (fi) Pyrido(1,2-a)pyrimidin-derivat foerfarande foer deras framstaellning och desamma innehaollande farmaceutiska blandningar
DK584288A (da) Fremgangsmaade til fremstilling af guaninderivater
DK71187A (da) Purinderivater
ES467943A1 (es) Un metodo de preparacion de una purina sustituida.
SE432764B (sv) Forfarande for framstellning av 2-amino-9-(2-hydroxietoximetyl) adenin och 9-(2-hydroxietoximetyl) guanin
IT8224311A0 (it) Derivati del pirimidin-4-one adattivita' erbicida.
NL7802111A (nl) 9-(2-hydroxyethoxymethyl) guaninemonofosfaat en zijn zouten.
DK448983A (da) 1-monophosphatestere, 1,3-bisphosphatestere og cykliske phosphatestere af 9-(1,3-dihydroxy-2-propoxymethyl)guanin som antivirale midler
KE3561A (en) Topical formulations of 9-(2-hydroxyethoxymethyl)guanine
SE7601928L (sv) Pyrimidin(2)yl-tionofosforsyraestrar till anvendning som insekticider och akaricider samt sett att framstella desamma
IT1222142B (it) Composizioni farmaceutiche antivirali
ZA833947B (en) Penetrating topical pharmaceutical compositions containing 9-(2-hydroxyethoxymethyl)guanine
NO930160D0 (no) Antivirale fosfono-alken-derivater av puriner
PH20807A (en) 2-amino-9-(2-hydroxyethoxymethyl)-9h-purine and salts thereof,their pharmaceutical formulations and their use
ES539795A0 (es) Procedimiento para la obtencion de 9-(2-hidroxietoximetil) guanina